Trending News
News
News
Wheaton Acquired By One Equity Partners
Acquisition will combine two of the world’s leading brands in laboratory consumables.
News
Combining Epigenetic Therapies and Immunotherapies Improves Cancer Outcomes
Recent data suggest that epigenetic therapies are likely to provide additional clinical benefit to cancer patients when rationally combined with immunotherapeutic drugs.
News
Merck Millipore Introduces Enhancements to its EMPROVE® Program
Instant, online access to regulatory and technical information on portfolio of 400 products.
News
Celgene, Nurix Announce Collaboration
The two companies are set to work on the discovery, development and commercialization of novel small molecule therapeutics in oncology, inflammation and immunology, including the rapidly evolving field of immunooncology.
News
Amgen To Acquire Privately-Held Dezima Pharma
This move strengthens Amgen's cardiovascular portfolio with late-stage, oral CETP inhibitor.
News
Preventing Crystallization to Improve Drug Efficiency
Esther Amstad and an international team of researchers have developed a method to increase the solubility of poorly soluble substances, such as many of the newly developed drugs.
News
Lipid Therapeutics Enters Licensing Agreement with Nestlé Health Science
Nestlé Health Science to develop and commercialize LT-02 worldwide, except in Europe and Australia.
News
Nuevolution Appoints Henrik Simonsen
Former Director of Life Science Corporate Finance at SEB joins as its Chief Financial Officer.
News
Auspherix, Domainex Expand Collaboration
The companies have announced an expansion of their collaboration to develop new drugs to tackle the growing threat of resistance to antibiotics.
News
Medelinked is the First Application to Feature in BioClinica’s App xChange
Patient and consumer-centred engagement technology extends eHealth clinical trial platform.
Advertisement